Archive for October 31, 2012

Good News for Metastatic Breast Cancer Patients

Share

By Erica L. Mayer, MD, MPH

There has been remarkable recent progress in identifying effective treatments for patients with metastatic breast cancer – that is, cancer that has spread beyond the breast and underarm lymph nodes to other parts of the body. Read more

Being Grateful in the Face of Cancer

Share

By Lola Baltzell

I have been a metastatic breast cancer patient at Dana-Farber for over four years now. “Metastatic” means the cancer has spread beyond the breast. I have an amazing team of providers, especially my oncologist Ann Partridge and nurse practitioner Anne Kelly. Read more

Nine Tips for Talking To Kids About Cancer

Share

 Helping a loved one face cancer is never easy, but the challenge is especially daunting when the patient is your own child. Our clinicians at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center work with pediatric cancer patients and their families every day. Lisa Diller, MD, Anna Muriel, MD, and Jorge Fernandez, LCSW – offer these 9 tips for talking with your children about their illness.           

Read more

When a Celebrity Has Breast Cancer

Share

by Erica Mayer, MD, MPH 

In 1974, when First Lady Betty Ford announced that she had undergone a mastectomy for breast cancer, it was a turning point in people’s willingness to talk about the disease. Prior to that, discussing cancer of any type, even with one’s family or friends, was often taboo. The First Lady’s openness about her cancer helped create a space in which women felt more comfortable talking about their experience – and about being screened for the disease.

Read more

Why Do Scientists Use Zebrafish to Study Cancer?

Share

Cancer scientists use a wide variety of techniques to study the growth and development of tumor cells. Laboratory research often focuses on individual cells or tissue samples, but to learn how cancers grow and respond to therapies in living organisms, scientists rely on other experimental models. In recent years, zebrafish have become the model of choice for studying many cancer types. Dana-Farber’s A. Thomas Look, MD, who uses zebrafish in his own work, explains why. Read more

From Patient to Caregiver: Alyssa Ywuc’s Story

Share

Alyssa Ywuc was a 23-year-old nursing student when she was diagnosed with leukemia. After seeing first-hand the work of oncology nurses as a patient, she decided to specialize in oncology nursing. We talked with Alyssa about both sides of the cancer experience – her time as a patient and her future career as a caregiver.

Read more

The HIV Spike, Revealed

Share

The gaudy green image you see below is not an avant-garde sculpture, but the most detailed image yet made of the protein “spike” that allows HIV – the virus that causes AIDS – to latch onto and enter human blood cells.

Read more

Breast Cancer, Aromatase Inhibitors, and Bone Density

Share

Aromatase inhibitors (AIs), such as Arimidex, Aromasin, and Femara, have proven to be more effective than previous hormonal treatments for treating both early and advanced breast cancer in post-menopausal women whose tumors are dependent on estrogen. Compared with tamoxifen, these drugs are less likely to cause blood clots or raise the risk of endometrial cancer. As a result, AIs are used both in patients with early breast cancer and in those with metastatic disease. Read more

Fun with Pink

Share

It was glitter and glue when patients, visitors, and Dana-Farber staff gathered on Oct. 4 to create art on an unusual canvas – bras. Hosted by Friends’ Place and Dana-Farber’s Creative Arts Program, the “Decorate a Brassiere” art therapy event allowed attendees to creatively honor Breast Cancer Awareness Month.

Read more

Dana-Farber Staff Join the Race

Share

This Sunday, 7,000 runners will step up to the starting line for the 12th annual Boston Athletic Association (BAA) Half Marathon presented by Dana-Farber and the Jimmy Fund. 500 of them will run not only to set a personal record on the 13.1-mile course, but also to raise money for Dana-Farber. Included in that group are a number of runners we’re happy to call our colleagues. Here are two of their stories.

Read more